Ablexis

Acquired

Ablexis is a biotech company in San Diego, United States, founded in 2009. It has raised $12.0M across 1 round, most recently a $12.0M Series A in June 2010.

Home - Ablexis Ablexis A superior, next generation transgenic mouse platform for the discovery of therapeutic antibodies

Employees
1–10
Founded
2009
Business Model
B2B
Total Funding
$12.0M
Last Round
$12.0M Series AJun 2010
Rounds
1
Acquisition Date
Jun 2018

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Founded in 2009, Ablexis is a biotechnology company that created the AlivaMab Mouse, a best-in-class transgenic mouse platform used by pharmaceutical and biotech partners to discover and develop human therapeutic antibodies. The company was built on technology developed at Aliva Biopharmaceuticals and is led by CEO Larry, a co-inventor of the XenoMouse technology with over 25 years of experience in transgenic antibody discovery. Ablexis licenses its AlivaMab Mouse platform to biopharmaceutical partners, with collaborations spanning major pharma companies such as Amgen, AstraZeneca, and Pfizer.

Summary

It lists 1–10 employees. It has raised $12.0M in total across 1 round, most recently a $12.0M Series A round in Jun 2010. Investors include Deerfield Management, Third Rock Ventures and Pfizer Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionJun 2018

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ablexis on Indexed.vc
<a href="https://indexed.vc/companies/ablexis"><img src="https://indexed.vc/api/badge/company/ablexis" alt="Ablexis on Indexed.vc" width="260" height="76" /></a>